4th Quarter - Report

TIBER CREEK GROUP for VERTEX PHARMACEUTICALS

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues surrounding treatment of rare diseases. Issues related to price and transparency. S 934 - FDA Reauthorization Act. Issues related to H.R.1 tax legislation Public Law 115-97. S. 1317 Medicaid and CHIP Quality Improvement Act.

LobbyistCovered position, as disclosed
JONATHON JONES —
SEAN RICHARDSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1317 (115th), H.R. 1 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.